Drug intelligence / Profile preview

GM-XANTHO

Development stage
Phase 2
Lead developer
Xantho Biotechnology Co., LTD
Modality
Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Hydrogel Systems → Drug Delivery Systems
Administration
Topical
01

Overview

GM-XANTHO is a topical botanical drug developed by Xantho Biotechnology for the treatment of atopic dermatitis, with additional clinical development in psoriasis and pressure ulcers. It is a non-steroidal, steroid-free cream formulated from herbal ingredients. The drug acts primarily by modulating immune responses in the skin—animal studies have shown it induces anti-inflammatory cytokine IL-10 production, reduces Th2 cytokines (including IL-4 and IgE), suppresses overexpression of IL-33 and CCL17 in keratinocytes, restores Th1/Th2 balance, repairs the skin barrier, alleviates itching, and lowers blood IgE levels. This comprehensive mechanism aims to reduce inflammation and recurrence rates without the side effects associated with corticosteroids or immunosuppressants[1][3][8]. Clinical trials have demonstrated efficacy for atopic dermatitis; ongoing studies are evaluating its use for psoriasis and wound healing (pressure ulcers)[3][8].

Brand names
GM-XANTHO
Other names
Garcinia mangostana fruit shell extract
02

Targets

IL33 (IL-33)IL10 (Interleukin-10)IL-4 (Interleukin 4)

Beyond the preview

Go deeper on GM-XANTHO.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GM-XANTHO.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call